Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
CALL
DexCom
DXCM
$32.9B
| $3.75M | ﹤0.01% |
+158,000
| New | +$3.35M |
|
1952
PUT
Microchip Technology
MCHP
$40.8B
| $3.75M | ﹤0.01% |
82,400
+46,200
| +128% | +$2.14M |
|
1953
PUT
Globus Medical
GMED
$11.1B
| $3.74M | ﹤0.01% |
+74,200
| New | +$3.87M |
|
1954
iShares Biotechnology ETF
IBB
$9.18B
| $3.74M | ﹤0.01% |
34,070
-191,637
| -85% | -$20.5M |
|
1955
Insperity
NSP
$2.05B
| $3.74M | ﹤0.01% |
39,283
-12,678
| -24% | -$1.09M |
|
|
STG
1956
Sunlands Technology
STG
$44.3M
| $3.74M | ﹤0.01% |
33,600
| – | – |
|
1957
CALL
Digital Realty Trust
DLR
$70.7B
| $3.73M | ﹤0.01% |
33,400
+4,900
| +17% | +$520K |
|
1958
PUT
Consolidated Edison
ED
$39.8B
| $3.73M | ﹤0.01% |
47,800
-28,800
| -38% | -$2.2M |
|
1959
AstraZeneca
AZN
$245B
| $3.72M | ﹤0.01% |
52,956
-20,154
| -28% | -$1.45M |
|
1960
United States Oil Fund
USO
$1.91B
| $3.71M | ﹤0.01% |
30,803
-188,961
| -86% | -$20.7M |
|
1961
Southern Copper
SCCO
$146B
| $3.71M | ﹤0.01% |
85,309
+28,454
| +50% | +$1.37M |
|
|
PMT
1962
PennyMac Mortgage Investment
PMT
$823M
| $3.7M | ﹤0.01% |
194,905
+162,893
| +509% | +$2.99M |
|
1963
Methanex
MEOH
$4.2B
| $3.7M | ﹤0.01% |
52,292
+44,682
| +587% | +$3M |
|
1964
PUT
ON Semiconductor
ON
$31.3B
| $3.69M | ﹤0.01% |
166,100
+119,800
| +259% | +$2.9M |
|
1965
O-I Glass
OI
$1.14B
| $3.69M | ﹤0.01% |
219,372
-55,221
| -20% | -$1.07M |
|
1966
Papa John's
PZZA
$1.02B
| $3.68M | ﹤0.01% |
72,621
+47,483
| +189% | +$2.66M |
|
1967
Skywest
SKYW
$4.42B
| $3.68M | ﹤0.01% |
70,974
-7,960
| -10% | -$445K |
|
1968
Medifast
MED
$108M
| $3.68M | ﹤0.01% |
22,989
+16,652
| +263% | +$2.13M |
|
1969
LCI Industries
LCII
$2.52B
| $3.68M | ﹤0.01% |
40,791
+20,571
| +102% | +$1.91M |
|
1970
PUT
SiriusXM
SIRI
$10.2B
| $3.68M | ﹤0.01% |
54,310
+51,800
| +2,064% | +$3.5M |
|
1971
CALL
Ciena
CIEN
$55.3B
| $3.67M | ﹤0.01% |
138,600
+14,600
| +12% | +$371K |
|
|
PDM
1972
Piedmont Realty Trust
PDM
$1.24B
| $3.67M | ﹤0.01% |
184,327
-2,195
| -1% | -$40.7K |
|
1973
Diamondrock Hospitality Co
DRH
$2.74B
| $3.67M | ﹤0.01% |
299,026
+63,305
| +27% | +$741K |
|
1974
CALL
Fortive
FTV
$18B
| $3.66M | ﹤0.01% |
+75,324
| New | +$3.6M |
|
1975
Element Solutions
ESI
$9.18B
| $3.66M | ﹤0.01% |
315,592
+240,227
| +319% | +$2.62M |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,614 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.